Series A - Notch Therapeutics
Investment Firm
Overview
Notch develops immune cell therapy developing a next-generation pipeline that is compatible and focuses on initial cancer cells.
Announced Date
Feb 10, 2021
Closed on Date
Feb 10, 2021
Funding Type
Series A
Highlights
Location
North America
Social
Investor Lead
N/A
Participant Investors
4
Round Details and Background
Notch Therapeutics raised $85000000 on 2021-02-10 in Series A
Notch develops immune cell therapy developing a next-generation pipeline that is compatible and focuses on initial cancer cells.
Company Funding History
5
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| Feb 10, 2021 |  Series A - Notch Therapeutics | 7 | - | 85.0M |
| Jan 01, 2018 | Non Equity Assistance - Notch Therapeutics | 1 | - | undefined |
| Jul 19, 2019 | Grant - Notch Therapeutics | 1 | - | 30.0K |
| Jun 14, 2024 | Venture Round - Notch Therapeutics | - | 15.5M |
Recent Activity
There is no recent news or activity for this profile.